tian zhang, md, on the follow up study investigating nivolumab ipilimumab in 1st line rcc patients
Published 4 years ago • 119 plays • Length 2:09
Download video MP4
Download video MP3
Similar videos
-
0:54
tian zhang, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
-
1:05
tian zhang, md, discusses intermediate/poor and favorable risk rcc patients
-
1:49
tian zhang on frontline therapy in rcc
-
1:21
tian zhang, md, offers perspective on treating newly diagnosed rcc patients
-
1:45
tian zhang, md, on predictive biomarkers in selecting patient populations for i-o treatment in rcc
-
1:28
tian zhang, md, discusses the most anticipated trial results regarding biomarkers in rcc
-
2:13
tian zhang, md, shares thoughts on the pdigree trial in metastatic, untreated rcc
-
1:22
tian zhang, md, regarding strategies for treating rcc in the 2nd line setting
-
58:47
making difficult treatment decisions in rcc
-
8:06
updates in treatment of renal cell carcinoma
-
8:27
my glowy glam makeup tutorial / tian zhang 闪亮轻欧美妆
-
1:58
tian zhang, md, elaborates on the pedigree clinical study in advanced renal cell cancer patients
-
2:38
tian zhang, md, on promising studies in sarcomatoid rcc & urothelial cancer from asco '19
-
1:11
dr. zhang on toxicities of treatments in rcc
-
1:04
tian zhang, md, elaborates on the outcomes of keynote 426 presented at gu 2019
-
1:08
dr. zhang on the importance of adjuvant clinical trials in rcc
-
4:02
practical selections for first line rcc therapy from pdigree: an alliance-led group study
-
1:17
tian zhang, md, on the evolving landscape of metastatic hormone-sensitive prostate cancer
-
0:44
michael atkins, md, on follow up investigation of checkmate 025 in renal cell carcinoma patients
-
5:02
seq-cabo: high-dose cabozantinib or nivolumab combination after progression in advanced rcc
-
5:46
dr. tian zhang - 2019 kca grant recipient
-
1:52
dr. zhang on potential of vaccines in rcc
Clip.africa.com - Privacy-policy